Stock Events

Stock Events

XBiotech 

$2.55
137
+$0+0% Tuesday 19:45

Statistics

Day High
2.58
Day Low
2.54
52W High
3.5
52W Low
2.12
Volume
14,265
Avg. Volume
-
Mkt Cap
77.74M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Dividends

0%Dividend Yield
Jul 21
$2.1
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

13MarExpected
Q2 2024
Q3 2024
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q4 2025
-0.88
-0.61
-0.33
-0.06
Expected EPS
N/A
Actual EPS
-0.88

Financials

-Profit Margin
Unprofitable
2019
2020
2021
2022
2023
2024
0Revenue
-77.06MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow XBIT. It's not an investment recommendation.
Alphabet
79493
GOOGL
Apple
69146
AAPL
Microsoft
64576
MSFT
Amazon
60260
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Regeneron Pharmaceuticals
REGN
Mkt Cap73.54B
Regeneron Pharmaceuticals competes in the biotechnology field, focusing on immunology and inflammatory diseases, similar to XBiotech's focus on True Human antibody therapies.
AMGEN
AMGN
Mkt Cap178B
Amgen is a biotech firm that develops innovative human therapeutics, including treatments for conditions in areas that XBiotech targets, making them direct competitors.
Gilead Sciences
GILD
Mkt Cap163.4B
Gilead Sciences is involved in the discovery, development, and commercialization of innovative therapeutics in areas of unmet medical need, overlapping with XBiotech's market.
Biogen
BIIB
Mkt Cap27.62B
Biogen focuses on neurology and rare diseases but also has a portfolio in immunology, competing with XBiotech in the broader biotech and therapeutic antibodies market.
Abbvie
ABBV
Mkt Cap365.43B
AbbVie operates in the same biopharmaceutical field as XBiotech, with a strong emphasis on immunology and oncology, areas where XBiotech also aims to innovate.
Merck
MRK
Mkt Cap277.02B
Merck & Co., Inc. is a global healthcare company that produces pharmaceuticals in various areas, including immunotherapy, where XBiotech is also striving to make advancements.
Pfizer
PFE
Mkt Cap149.77B
Pfizer is a large pharmaceutical company with a diverse portfolio, including immunology and oncology, competing with XBiotech in the development of novel treatments.
Johnson & Johnson
JNJ
Mkt Cap546.9B
Johnson & Johnson, through its pharmaceutical segment Janssen, competes in the same therapeutic areas as XBiotech, including immunology and oncology.
Bristol-Myers Squibb
BMY
Mkt Cap118.87B
Bristol-Myers Squibb is focused on discovering, developing, and delivering innovative medicines that help patients prevail over serious diseases, including areas where XBiotech is active.
Novartis
NVS
Mkt Cap279.67B
Novartis is a global healthcare company that operates in various segments, including innovative medicines in areas like immunology, directly competing with XBiotech's research and development focus.

About

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes True Human monoclonal antibodies for treating various diseases. The company focuses on developing a pipeline of product candidates targeting both inflammatory and infectious diseases. It is also developing interleukin-1 alpha therapies to treat variety of medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and inflammation, and True Human COVID-19 therapy for treating the COVID-19 mutant virus. The company was incorporated in 2005 and is headquartered in Austin, Texas.
Show more...
CEO
Mr. John Simard
Employees
92
Country
Canada
ISIN
CA98400H1029

Listings

MU
DE
4XB.MU
STU
DE
4XB.STU
F
DE
4XB.F
BOATS
BOATS
XBIT.BOATS

0 Comments

Share your thoughts

FAQ

What is XBiotech stock price today?▼
The current price of XBIT is $2.55 USD — it has increased by +0% in the past 24 hours. Watch XBiotech stock price performance more closely on the chart.
What is XBiotech stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange XBiotech stocks are traded under the ticker XBIT.
Is XBiotech stock price growing?▼
XBIT stock has risen by +1.19% compared to the previous week, the month change is a +9.91% rise, over the last year XBiotech has showed a -8.27% decrease.
What is XBiotech market cap?▼
Today XBiotech has the market capitalization of 77.74M
What were XBiotech earnings last quarter?▼
XBIT earnings for the last quarter are -0.88 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is XBiotech revenue for the last year?▼
XBiotech revenue for the last year amounts to 0 USD.
What is XBiotech net income for the last year?▼
XBIT net income for the last year is -77.06M USD.
Does XBiotech pay dividends?▼
Yes, XBIT dividends are paid en. The last dividend per share was 2.1 USD. As of today, Dividend Yield (FWD)% is 0%.
How many employees does XBiotech have?▼
As of May 06, 2026, the company has 92 employees.
In which sector is XBiotech located?▼
XBiotech operates in the Health & Wellness sector.
When did XBiotech complete a stock split?▼
XBiotech has not had any recent stock splits.
Where is XBiotech headquartered?▼
XBiotech is headquartered in Austin, Canada.